SHAILY ENGINEERING PLASTICS LTD.

Shaily Engineering Plastics Ltd has submitted the final Annual Report for FY 2025-26, incorporating minor changes to photographs on pages 2 and 3. The report highlights significant investments of ₹585.29 Cr over five years, leading to an 1,140 basis point improvement in ROCE. The company is expanding into high-growth sectors like semiconductors, EVs, aerospace, defense, and medical devices, with a particular focus on its healthcare vertical, which grew 139% to ₹392.8 Cr, now representing 40% of consolidated revenue. Shaily is evolving into a technology partner, emphasizing precision manufacturing, advanced materials, and a reduced environmental footprint.

Shaily Engineering Plastics Ltd has announced its 46th Annual General Meeting (AGM) will be held on Monday, September 28, 2026, at 11:00 AM IST. The meeting will be conducted via Video Conferencing (VC) / Other Audio-Visual Means (OAVM). Key agenda items include the adoption of the Audited Standalone and Consolidated Financial Statements for the fiscal year ended March 31, 2026, the declaration of a dividend of ₹3 per equity share for FY 2025-26, the re-appointment of Mr. Mahendra Sanghvi as a director, and the ratification of remuneration for the Cost Auditors for FY 2026-27. Additionally, the AGM will address changes in the remuneration of Ms. Kinjal Bhavsar, Managing Director of Shaily Innovations Limited.

Shaily Engineering Plastics Ltd has submitted its 46th Annual Report for the Financial Year ended March 31, 2026. The company has scheduled its 46th Annual General Meeting (AGM) for Monday, September 28, 2026, at 11:00 a.m. IST, to be conducted via Video Conferencing (VC) / Other Audio-Visual Means (OAVM). The report highlights significant investments in capabilities and infrastructure, leading to improved ROCE and profitable growth. It also details the company's strategic focus on emerging sectors like semiconductors, EVs, aerospace, and defense, alongside advancements in precision manufacturing, quality control (Quality 4.0), and sustainable practices (ESG). Healthcare is identified as a key growth engine, with revenue increasing by 139% to ₹392.8 Cr, now contributing 40% of consolidated revenue.

Shaily Engineering Plastics Ltd has submitted its Business Responsibility and Sustainability Report (BRSR) for the Financial Year ended March 31, 2026. The report, prepared on a standalone basis, details the company's business activities, operations, and employee data. Shaily Engineering Plastics is engaged in the manufacturing of plastic products, non-metallic mineral products, rubber products, and fabricated metal products, with 100% of its turnover derived from this segment. Exports contributed 67.7% of the total turnover for FY 2025-26. The company serves diverse industries including home furnishings, medical devices, FMCG, automotive, and electronics.

Shaily Engineering Plastics Ltd announced the re-appointment of Mr. Amit Sanghvi as Managing Director for a term of five years, effective October 1, 2026, to September 30, 2031. This reappointment is subject to shareholder approval at the upcoming 46th Annual General Meeting. The Board also approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, and fixed September 11, 2026, as the record date for the final dividend for FY 2025-26. Additionally, a revised Code of Conduct for Prevention of Insider Trading was approved.

Shaily Engineering Plastics Ltd announced the re-appointment of Mr. Amit Sanghvi as Managing Director for a term of five years, effective October 1, 2026, through September 30, 2031. This decision was made during the Board of Directors' meeting on August 8, 2026, and is subject to shareholder approval at the upcoming 46th Annual General Meeting (AGM). The board also approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. Additionally, the company fixed September 11, 2026, as the record date for determining shareholders eligible for the final dividend for FY 2025-26 and approved a revised Code of Conduct for Prevention of Insider Trading.

Shaily Engineering Plastics Ltd announced that its Board of Directors, in a meeting held on August 8, 2026, approved the Unaudited Standalone & Consolidated Financial Results for the quarter ended June 30, 2026. Additionally, the Board re-appointed Mr. Amit Mahendra Sanghvi as Managing Director for a five-year term starting October 1, 2026, subject to shareholder approval. Crucially, the company has fixed September 11, 2026, as the record date to determine shareholders eligible for the final dividend for the Financial Year 2025-26. The Board also approved a revised Code of Conduct for Prevention of Insider Trading.

Shaily Engineering Plastics' consolidated revenue came in at ₹280.67 Cr, up 13.8% YoY (₹246.69 Cr) and 18.5% QoQ (₹236.82 Cr), with consolidated PAT of ₹48.01 Cr, up 16.7% YoY (₹41.12 Cr) and 19.6% QoQ (₹40.16 Cr). Neither this quarter nor the year-ago quarter carries an exceptional item, so the growth is on a clean, like-for-like basis. On a standalone (parent-only) basis the print is stronger still — revenue ₹274.78 Cr and PAT ₹52.47 Cr, running ₹4.46 Cr ahead of the consolidated PAT. The gap between the two bases is fully explained by one overseas subsidiary: its interim financials, not yet reviewed by the auditor, show a ₹1.97 Cr net loss on ₹1.43 Cr of revenue for the quarter, which the auditor's limited-review report flags as immaterial to the group. On profitability, operating margin (revenue less all costs excluding finance cost and depreciation) expanded to 29.6% this quarter from 27.7% both a year ago and last quarter — roughly 190 bps of YoY expansion — while consolidated net margin improved to 17.1% from 16.5% YoY. That expansion lines up with the healthcare-led mix shift (pen injectors, plus emerging consumer-electronics and semiconductor-tray lines) management has been pointing to. Management gave no formal quantitative guidance on the Q4 FY26 call — only a qualitative outlook of "profitable and sustainable growth" from new healthcare capacity and "strong potential for margin improvement"; this quarter's ~190 bps YoY OPM expansion is directionally consistent with that framing, so it reads as on-track rather than a clear beat or miss against a number. No management press release accompanying this filing was available in our records, so this read rests solely on the results statement and the prior concall. A web search for Street consensus on this print turned up only a generic near-term price-target note contingent on the quarter "meeting expectations," with no PAT or revenue estimate attached, so vsStreet is marked unknown rather than guessed. Separately, the company allotted 40,155 ESOP shares during the quarter, taking paid-up equity to 4,59,95,248 shares of ₹2 each, and the board that approved these results also fixed a dividend record date. Going into H2 FY27, the two markers to watch are the pace of Semaglutide pen-injector capacity utilisation — management has spoken of reaching full utilisation over the next two years — and progress on the Abu Dhabi healthcare capacity build-out; whether the OPM can hold above the 29% now printed, against continued capacity ramp-up costs, will be the key margin checkpoint next quarter.

Shaily Engineering Plastics Ltd announced the outcome of its Board Meeting held on August 8, 2026. The board considered and approved the Unaudited Standalone & Consolidated Financial Results for the quarter ended June 30, 2026. Additionally, the re-appointment of Mr. Amit Mahendra Sanghvi as Managing Director was approved, effective October 1, 2026, subject to shareholder approval. The company also fixed September 11, 2026, as the record date for determining members entitled to the final dividend for FY 2025-26. A revised Code of Conduct for Prevention of Insider Trading was also approved.

Shaily Engineering Plastics Ltd has announced that its Board of Directors meeting is scheduled for August 8, 2026. The primary agenda is to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. Additionally, the company will note a change in reporting format, transitioning from Lacs to Crores for its financial results starting from the quarter ended June 30, 2026. The trading window for insiders was closed from July 1, 2026, and will reopen 48 hours after the results declaration, with the closure period extending until August 10, 2026.